SANOFI (1SAN.MI) Stock Price, Quote, News and Overview
BIT:1SAN - Borsa Italiana Milan - FR0000120578 - Common Stock - Currency: EUR
1SAN.MI Quote, Performance and Key Statistics
SANOFI
BIT:1SAN (1/31/2025, 7:00:00 PM)
104.08
+2.06 (+2.02%)
The current stock price of 1SAN.MI is 104.08 EUR. In the past month the price increased by 4.04%.
1SAN.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY.DE | ELI LILLY & CO | 81.81 | 764.20B | ||
| 1LLY.MI | ELI LILLY & CO | 79.43 | 741.99B | ||
| ZEG.DE | ASTRAZENECA PLC | 18.22 | 413.69B | ||
| NOV.DE | NOVO NORDISK A/S-B | 28.98 | 365.43B | ||
| JNJ.DE | JOHNSON & JOHNSON | 15.25 | 355.12B | ||
| 1JNJ.MI | JOHNSON & JOHNSON | 15.23 | 354.69B | ||
| SAN.PA | SANOFI | 14.61 | 257.91B | ||
| SNW.DE | SANOFI | 14.58 | 257.34B | ||
| 1MRKX.MI | MERCK & CO. INC. | 16.39 | 238.80B | ||
| 6MK.DE | MERCK & CO. INC. | 15.1 | 220.08B | ||
| 1PFE.MI | PFIZER INC | 10.24 | 145.02B | ||
| PFE.DE | PFIZER INC | 10 | 141.65B |
Related stock screener links
About 1SAN.MI
Company Profile
Sanofi engages in the research, production, and distribution of pharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 87,994 full-time employees. The company went IPO on 2002-07-01. The firm focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company Info
SANOFI
46 Avenue de la Grande Armee
Paris ILE-DE-FRANCE FR
Employees: 86088
Company Website: https://www.sanofi.com/
Investor Relations: https://www.sanofi.com/en/investors
Phone: 33153774000
1SAN.MI FAQ
What is the stock price of 1SAN.MI?
The current stock price of 1SAN.MI is 104.08 EUR.
What is the symbol for SANOFI stock?
The exchange symbol of SANOFI is 1SAN and it is listed on the Borsa Italiana Milan exchange.
On which exchange is 1SAN.MI stock listed?
1SAN.MI stock is listed on the Borsa Italiana Milan exchange.
Is 1SAN.MI a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for 1SAN.MI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of 1SAN.MI.
Does 1SAN.MI stock pay dividends?
1SAN.MI has a dividend yield of 3.63%. The yearly dividend amount is currently 3.56.
What is the Price/Earnings (PE) ratio of 1SAN.MI?
The PE ratio for 1SAN.MI is 14.78. This is based on the reported non-GAAP earnings per share of 7.04 and the current share price of 104.08 EUR.
1SAN.MI Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to 1SAN.MI.
1SAN.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 1SAN.MI. While 1SAN.MI has a great profitability rating, there are quite some concerns on its financial health.
1SAN.MI Financial Highlights
Over the last trailing twelve months 1SAN.MI reported a non-GAAP Earnings per Share(EPS) of 7.04. The EPS increased by -13.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.97% | ||
| ROA | 9% | ||
| ROE | 15.37% | ||
| Debt/Equity | 0.17 |
1SAN.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 79% to 1SAN.MI. The Buy consensus is the average rating of analysts ratings from 28 analysts.
For the next year, analysts expect an EPS growth of 18.08% and a revenue growth 6.46% for 1SAN.MI